Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Axogen, Inc. before investing.

In this article, we go over a few key elements for understanding Axogen, Inc.’s stock price such as:

• Axogen, Inc.’s current stock price and volume
• Why Axogen, Inc.’s stock price changed recently
• Upgrades and downgrades for AXGN from analysts
• AXGN’s stock price momentum as measured by its relative strength

About Axogen, Inc. (AXGN)

Before we jump into Axogen, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.

Want to learn more about Axogen, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Axogen, Inc..

Axogen, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 1:00 PM, CST, Axogen, Inc.’s stock price was $41.415.

Axogen, Inc. is up 0.16% from its previous closing price of $41.350.

During the last market session, Axogen, Inc.’s stock traded between $39.920 and $41.780. Currently, there are approximately 51.59 million shares outstanding for Axogen, Inc..

Axogen, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Axogen, Inc. Stock Price History

Axogen, Inc.’s (AXGN) price is currently down 10.34% so far this month.

During the month of July, Axogen, Inc.’s stock price has reached a high of $46.950 and a low of $38.230.

Over the last year, Axogen, Inc. has hit prices as high as $46.950 and as low as $12.385. Year to date, Axogen, Inc.’s stock is up 26.54%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Axogen, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there was 1 analyst who downgraded Axogen, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Axogen, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Axogen, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Axogen, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Axogen, Inc. (AXGN) by visiting AAII Stock Evaluator.

Relative Price Strength of Axogen, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, Axogen, Inc. has a weighted four-quarter relative price strength of 24.18%, which translates to a Momentum Score of 94 and is considered to be Very Strong.

Want to learn more about how Axogen, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Axogen, Inc. Stock Price: Bottom Line

As of July 31, 2026, Axogen, Inc.’s stock price is $41.415, which is up 0.16% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Axogen, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.